Central diabetes insipidus in refractory antineutrophil cytoplasmic antibody-associated vasculitis

Keiji Ohashi, Michiko Morishita, Haruki Watanabe, Ken Ei Sada, Takayuki Katsuyama, Yoshia Miyawaki, Eri Katsuyama, Mariko Narazaki, Noriko Tatebe, Katsue Watanabe, Tomoko Kawabata, Jun Wada

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We herein describe two cases of refractory antineutrophil cytoplasmic antibody-associated vasculitis (AAV) complicated with diabetes insipidus (DI) possibly related to hypertrophic pachymeningitis (HP). One patient had microscopic polyangiitis and HP, which were refractory to cyclophosphamide, azathioprine, rituximab, mycophenolate mofetil (MMF), and mizoribine. Remission was finally achieved with the use of etanercept, but DI occurred 5 years later. The other patient had granulomatosis with polyangiitis, which that was refractory to cyclophosphamide, methotrexate, MMF, and rituximab. DI subsequently developed, but was successfully treated with etanercept. Dura mater hypertrophy was macroscopically observed in the latter case.

Original languageEnglish
Pages (from-to)2943-2948
Number of pages6
JournalInternal Medicine
Volume56
Issue number21
DOIs
Publication statusPublished - 2017

Keywords

  • Antineutrophil cytoplasmic antibody-associated vasculitis
  • Diabetes insipidus
  • Etanercept
  • Hypertrophic pachymeningitis
  • Rituximab

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Central diabetes insipidus in refractory antineutrophil cytoplasmic antibody-associated vasculitis'. Together they form a unique fingerprint.

  • Cite this

    Ohashi, K., Morishita, M., Watanabe, H., Sada, K. E., Katsuyama, T., Miyawaki, Y., Katsuyama, E., Narazaki, M., Tatebe, N., Watanabe, K., Kawabata, T., & Wada, J. (2017). Central diabetes insipidus in refractory antineutrophil cytoplasmic antibody-associated vasculitis. Internal Medicine, 56(21), 2943-2948. https://doi.org/10.2169/internalmedicine.8683-16